TLR3 and Zika virus infectious disease: Inhibition of TLR3/dsRNA by competitive inhibitor (thiophenecarboxamidopropionate) resulted in reversal of these phenotypic effects, while treatment with TLR3 agonist (poly I:C) mimicked ZIKV infection in terms of brain organoid volume (20).